Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-21

FDA Approved: ATAZANAVIR — Supplemental Application (Laurus Labs Limited)

View source ↗

Summary

FDA approved a supplemental application for atazanavir submitted by Laurus Labs Limited (ANDA 212579).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATAZANAVIR (atazanavir)

Snippet

SUPPL AP for ATAZANAVIR (ATAZANAVIR)